Correction to Lancet Oncol 2015; 16: 747. EGFR mutations and EGFR tyrosine kinase inhibitors
- PMID: 26149882
- DOI: 10.1016/S1470-2045(15)00082-0
Correction to Lancet Oncol 2015; 16: 747. EGFR mutations and EGFR tyrosine kinase inhibitors
Erratum for
-
EGFR mutations and EGFR tyrosine kinase inhibitors.Lancet Oncol. 2015 Jul;16(7):746-8. doi: 10.1016/S1470-2045(15)00028-5. Epub 2015 Jun 4. Lancet Oncol. 2015. PMID: 26051233 No abstract available.
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
